![Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance](https://openbiomarkerjournal.com/contents/volumes/V9/TOBIOMJ-9-70/TOBIOMJ-9-70_F2.jpg)
Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance
![Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area](https://www.mdpi.com/diagnostics/diagnostics-12-02822/article_deploy/html/images/diagnostics-12-02822-g001-550.jpg)
Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/30b3a6ab-da44-4a85-aa46-5cbc9fc28cc8/gr1_lrg.gif)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
![PDF] Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population | Semantic Scholar PDF] Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f29f4fb4366554f0759bafb8265a11cd85f7a04/4-Table1-1.png)
PDF] Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population | Semantic Scholar
![Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. | Semantic Scholar Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a739cfa323cfc4538e72bd2b631efb4c97059d0e/5-Figure2-1.png)
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. | Semantic Scholar
![Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan](https://www.mdpi.com/diagnostics/diagnostics-10-00159/article_deploy/html/images/diagnostics-10-00159-g001-550.jpg)
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
View of The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States | Annals of Gastroenterology
![Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/49e98917-4058-4b9d-a18b-1d4d8f67ab34/gr2_lrg.jpg)
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
![Results of Fibroscan, CAP, NAFLD Fibrosis Score, FIB 4, and FAST Score... | Download Scientific Diagram Results of Fibroscan, CAP, NAFLD Fibrosis Score, FIB 4, and FAST Score... | Download Scientific Diagram](https://www.researchgate.net/publication/369058423/figure/tbl3/AS:11431281125190786@1678229958221/Results-of-Fibroscan-CAP-NAFLD-Fibrosis-Score-FIB-4-and-FAST-Score-in-NAFLD-Group.png)
Results of Fibroscan, CAP, NAFLD Fibrosis Score, FIB 4, and FAST Score... | Download Scientific Diagram
![Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-93294-6/MediaObjects/41598_2021_93294_Fig1_HTML.png)